Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 1,000 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Daniel Trencher sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 17th. The shares were sold at an average price of $13.21, for a total transaction of $13,210.00. Following the transaction, the insider now directly owns 26,192 shares of the company’s stock, valued at $345,996.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Daniel Trencher also recently made the following trade(s):

• On Monday, March 18th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The stock was sold at an average price of $15.18, for a total value of $15,180.00.
• On Monday, March 4th, Daniel Trencher sold 6,780 shares of Teladoc Health stock. The stock was sold at an average price of $14.52, for a total value of $98,445.60.
• On Tuesday, February 20th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The stock was sold at an average price of $20.64, for a total transaction of $20,640.00.

Teladoc Health Price Performance

TDOC opened at $13.14 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The stock’s fifty day moving average is $15.89 and its two-hundred day moving average is $17.98. Teladoc Health, Inc. has a 52 week low of $13.03 and a 52 week high of $30.41.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company had revenue of $660.50 million during the quarter, compared to analyst estimates of $670.79 million. During the same period in the prior year, the firm earned ($0.23) earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. As a group, analysts predict that Teladoc Health, Inc. will post -1.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on TDOC shares. SVB Leerink assumed coverage on shares of Teladoc Health in a research report on Monday, February 26th. They set a “market perform” rating and a $17.00 price objective on the stock. Piper Sandler cut their price objective on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Royal Bank of Canada decreased their target price on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 21st. DA Davidson cut their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Finally, Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $34.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, February 21st. Eight equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $22.23.

Institutional Investors Weigh In On Teladoc Health

Hedge funds have recently made changes to their positions in the stock. MetLife Investment Management LLC purchased a new position in Teladoc Health in the first quarter worth $218,000. Panagora Asset Management Inc. grew its stake in Teladoc Health by 18.8% during the 1st quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock worth $1,205,000 after buying an additional 2,640 shares during the last quarter. Rhumbline Advisers grew its stake in Teladoc Health by 2.3% during the 1st quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock worth $9,443,000 after buying an additional 2,921 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in Teladoc Health by 10.8% in the first quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock valued at $8,237,000 after buying an additional 10,559 shares during the last quarter. Finally, Raymond James Trust N.A. raised its stake in Teladoc Health by 7.8% in the first quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock valued at $826,000 after buying an additional 827 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.